CLDX vs LNTH
Celldex Therapeutics, Inc. - Common Stock · Lantheus Holdings, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | CLDX | LNTH |
|---|---|---|
| Price | $37.51 | $100.00 |
| Market Cap | $2.94B | $6.51B |
| P/E | — | 27.88 |
| P/B | 6.45 | 5.37 |
| P/S | 1905.66 | 4.22 |
| ROE | -56.7% | 19.3% |
| Net Margin | -16748.0% | 15.2% |
| Gross Margin | — | 61.1% |
| Revenue Growth | -78.0% | 0.5% |
| Dividend Yield | — | — |
| EPS | -$3.30 | $3.59 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.